Legend Capital, the venture and growth capital arm of China’s Legend Holdings Ltd, has co-led an RMB2 billion ($293 million) investment in Chinese Diagnostics Medical Corporation by joining China Renaissance’s healthcare fund, China Money Network reported.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in